Literature DB >> 18314295

Can urban methadone patients complete health utility assessments?

Paul A Teixeira1, Bruce R Schackman.   

Abstract

OBJECTIVE: To assess the ability of methadone maintenance treatment (MMT) patients to use two standardized health assessment tools to value health states related to chronic hepatitis C virus (HCV) infection and HCV treatment-associated side effects. An estimated 65-90% of MMT patients are chronically infected with HCV.
METHODS: We employed qualitative methods to explore how patients completed computerized rating scale assessments and standard gamble utility assessments by (1) having them discuss their responses in a think-aloud interview immediately after each health state assessment, and (2) allowing them the opportunity to recalibrate prior responses after considering subsequent health states.
RESULTS: MMT patients used the rating scale boundaries appropriately and used the standard gamble to rank the health states in an a priori logical order. A guided assessment approach that allowed recalibration provided additional insight into values assigned to the health states presented.
CONCLUSION: MMT patients are able to perform the tasks associated with rating scale assessments and standard gamble utility assessments of HCV health states. PRACTICE IMPLICATIONS: These assessment methods should be considered as a means to elicit MMT patients' values for HCV treatment, since the treatment outcome is uncertain but it is likely that side effects will adversely affect current health.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18314295      PMCID: PMC2361157          DOI: 10.1016/j.pec.2008.01.010

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  30 in total

Review 1.  National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002.

Authors: 
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

2.  Shared decision making in hypertension: the impact of patient preferences on treatment choice.

Authors:  A A Montgomery; J Harding; T Fahey
Journal:  Fam Pract       Date:  2001-06       Impact factor: 2.267

3.  A trial for comparing methods for eliciting treatment preferences from men with advanced prostate cancer: results from the initial visit.

Authors:  J Souchek; J R Stacks; B Brody; C M Ashton; R B Giesler; M M Byrne; K Cook; J M Geraci; N P Wray
Journal:  Med Care       Date:  2000-10       Impact factor: 2.983

Review 4.  Stability of patients' preferences for chemotherapy: the impact of experience.

Authors:  S J Jansen; J Kievit; M A Nooij; A M Stiggelbout
Journal:  Med Decis Making       Date:  2001 Jul-Aug       Impact factor: 2.583

5.  Health-related quality of life in chronic liver disease: the impact of type and severity of disease.

Authors:  Z M Younossi; N Boparai; L L Price; M L Kiwi; M McCormick; G Guyatt
Journal:  Am J Gastroenterol       Date:  2001-07       Impact factor: 10.864

6.  Sharing of drug preparation equipment as a risk factor for hepatitis C.

Authors:  H Hagan; H Thiede; N S Weiss; S G Hopkins; J S Duchin; E R Alexander
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

7.  Cognitive impairment among methadone maintenance patients.

Authors:  S Darke; J Sims; S McDonald; W Wickes
Journal:  Addiction       Date:  2000-05       Impact factor: 6.526

8.  Quality-of-life tradeoffs for hepatitis C treatment: do patients and providers agree?

Authors:  Bruce R Schackman; Paul A Teixeira; Gil Weitzman; Alvin I Mushlin; Ira M Jacobson
Journal:  Med Decis Making       Date:  2008-03-18       Impact factor: 2.583

9.  Offers of hepatitis C care do not lead to treatment.

Authors:  Bruce R Schackman; Paul A Teixeira; Ann B Beeder
Journal:  J Urban Health       Date:  2007-05       Impact factor: 3.671

10.  Cognitive impairment in methadone maintenance patients.

Authors:  Miriam Z Mintzer; Maxine L Stitzer
Journal:  Drug Alcohol Depend       Date:  2002-06-01       Impact factor: 4.492

View more
  1 in total

Review 1.  Review of patient-reported outcome measures in chronic hepatitis C.

Authors:  Leah Kleinman; Sally Mannix; Yong Yuan; Shannon Kummer; Gilbert L'Italien; Dennis Revicki
Journal:  Health Qual Life Outcomes       Date:  2012-08-07       Impact factor: 3.186

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.